These phenotypes were further supported with additional immune markers including PD-1, PD-L1, granzyme B, FoxP3, CD20, CD4, CD3, CD45RO, TCF1, CD103, and CD95 to investigate the complexity of immunity in the tumor microenvironment of the lung cancer patients’ tissues. The gene discussed is CD274; the disease is neoplasm.